Shopping Cart
- Remove All
Your shopping cart is currently empty
Edotecarin is a potent topoisomerase I inhibitor. It can decrease single-strand DNA cleavage (IC50: 50 nM).

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $2,570 | 3-6 months | |
| 50 mg | $3,380 | 3-6 months | |
| 100 mg | $4,600 | 3-6 months |
| Description | Edotecarin is a potent topoisomerase I inhibitor. It can decrease single-strand DNA cleavage (IC50: 50 nM). |
| Targets&IC50 | PKC:160 μM, Topo I:50 nM |
| In vitro | Edotecarin (0.6 μmol/L) increases the formation of DNA-protein complexes in a time-dependent manner, in the presence of human colon cancer cells labeled with 3Hthymidine [1]. |
| In vivo | Edotecarin significantly delays tumor growth, achieving a delay of 10.45 days at a dosage of 3 mg/kg and extending up to 24.83 days at 100 mg/kg. It enhances survival by 83% in mice with D-456MG glioma intracranial tumors and exhibits potent antimetastatic properties [1]. Additionally, combining edotecarin with irinotecan elevates its in vivo antitumor efficacy beyond that observed with either compound individually [2]. |
| Synonyms | PF 804950, J 107088 |
| Molecular Weight | 608.55 |
| Formula | C29H28N4O11 |
| Cas No. | 174402-32-5 |
| Relative Density. | 1.96g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.